NTRK1 and acute myeloid leukemia: After mining large publicly available datasets (e.g., Microarray Innovations in Leukemia (MILE) study), Herbrich et al. (2018) reported that expression of NTRK1 was significantly higher in a combined group of 456 patients with AML when compared with normal CD34+ bone marrow cells [86].